Brainstorm Cell Therapeutics, Inc. (BCLI)

0.75 +0.03 (+4.02%) USD  |  OTCM  |  May 29, 16:00
More

Brainstorm Cell Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for BCLI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
NovelStem International Corp. Upgrade
Summit Therapeutics, Inc. Upgrade
Kezar Life Sciences, Inc. Upgrade
Protara Therapeutics, Inc. Upgrade
Clene, Inc. Upgrade